The observed anti-inflammatory and protective effects by compound 11a-1 in our LPS-induced endotoxemia model suggest that Shp2 inhibition may provide a potential strategy for combating endotoxemia. Here, PTPN11 is linked to serum lipopolysaccharide activity.